nodes	percent_of_prediction	percent_of_DWPC	metapath
Clavulanate—Pain—Thalidomide—hematologic cancer	0.000842	0.000842	CcSEcCtD
Clavulanate—Pruritus—Lenalidomide—hematologic cancer	0.000839	0.000839	CcSEcCtD
Clavulanate—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000838	0.000838	CcSEcCtD
Clavulanate—Diarrhoea—Melphalan—hematologic cancer	0.000835	0.000835	CcSEcCtD
Clavulanate—Nausea—Chlorambucil—hematologic cancer	0.000831	0.000831	CcSEcCtD
Clavulanate—Vomiting—Vinblastine—hematologic cancer	0.000815	0.000815	CcSEcCtD
Clavulanate—Nausea—Nilotinib—hematologic cancer	0.000813	0.000813	CcSEcCtD
Clavulanate—Diarrhoea—Lenalidomide—hematologic cancer	0.000811	0.000811	CcSEcCtD
Clavulanate—Urticaria—Thiotepa—hematologic cancer	0.000808	0.000808	CcSEcCtD
Clavulanate—Pain—Carmustine—hematologic cancer	0.000808	0.000808	CcSEcCtD
Clavulanate—Nausea—Imatinib—hematologic cancer	0.000808	0.000808	CcSEcCtD
Clavulanate—Hypersensitivity—Bortezomib—hematologic cancer	0.000804	0.000804	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Methotrexate—hematologic cancer	0.000802	0.000802	CcSEcCtD
Clavulanate—Leukopenia—Etoposide—hematologic cancer	0.000802	0.000802	CcSEcCtD
Clavulanate—Pain—Alitretinoin—hematologic cancer	0.000801	0.000801	CcSEcCtD
Clavulanate—Diarrhoea—Hydroxyurea—hematologic cancer	0.0008	0.0008	CcSEcCtD
Clavulanate—Anaphylactic shock—Cisplatin—hematologic cancer	0.000798	0.000798	CcSEcCtD
Clavulanate—Hypersensitivity—Bleomycin—hematologic cancer	0.000798	0.000798	CcSEcCtD
Clavulanate—Nausea—Cladribine—hematologic cancer	0.000794	0.000794	CcSEcCtD
Clavulanate—Pain—Ifosfamide—hematologic cancer	0.000792	0.000792	CcSEcCtD
Clavulanate—Hypersensitivity—Vinorelbine—hematologic cancer	0.000785	0.000785	CcSEcCtD
Clavulanate—Urticaria—Thalidomide—hematologic cancer	0.000782	0.000782	CcSEcCtD
Clavulanate—Thrombocytopenia—Cisplatin—hematologic cancer	0.000781	0.000781	CcSEcCtD
Clavulanate—Convulsion—Etoposide—hematologic cancer	0.000776	0.000776	CcSEcCtD
Clavulanate—Vomiting—Melphalan—hematologic cancer	0.000776	0.000776	CcSEcCtD
Clavulanate—Pruritus—Bortezomib—hematologic cancer	0.000772	0.000772	CcSEcCtD
Clavulanate—Pain—Vincristine—hematologic cancer	0.000772	0.000772	CcSEcCtD
Clavulanate—Rash—Melphalan—hematologic cancer	0.000769	0.000769	CcSEcCtD
Clavulanate—Dermatitis—Melphalan—hematologic cancer	0.000768	0.000768	CcSEcCtD
Clavulanate—Pruritus—Bleomycin—hematologic cancer	0.000766	0.000766	CcSEcCtD
Clavulanate—Convulsion—Prednisolone—hematologic cancer	0.000765	0.000765	CcSEcCtD
Clavulanate—Eosinophilia—Methotrexate—hematologic cancer	0.000762	0.000762	CcSEcCtD
Clavulanate—Nausea—Vinblastine—hematologic cancer	0.000762	0.000762	CcSEcCtD
Clavulanate—Hypokalaemia—Epirubicin—hematologic cancer	0.000759	0.000759	CcSEcCtD
Clavulanate—Vomiting—Lenalidomide—hematologic cancer	0.000754	0.000754	CcSEcCtD
Clavulanate—Pruritus—Vinorelbine—hematologic cancer	0.000754	0.000754	CcSEcCtD
Clavulanate—Pain—Irinotecan—hematologic cancer	0.000752	0.000752	CcSEcCtD
Clavulanate—Pain—Mitoxantrone—hematologic cancer	0.000752	0.000752	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Epirubicin—hematologic cancer	0.000751	0.000751	CcSEcCtD
Clavulanate—Hypersensitivity—Thiotepa—hematologic cancer	0.00075	0.00075	CcSEcCtD
Clavulanate—Rash—Lenalidomide—hematologic cancer	0.000748	0.000748	CcSEcCtD
Clavulanate—Dermatitis—Lenalidomide—hematologic cancer	0.000747	0.000747	CcSEcCtD
Clavulanate—Diarrhoea—Bortezomib—hematologic cancer	0.000747	0.000747	CcSEcCtD
Clavulanate—Urticaria—Alitretinoin—hematologic cancer	0.000744	0.000744	CcSEcCtD
Clavulanate—Vomiting—Hydroxyurea—hematologic cancer	0.000744	0.000744	CcSEcCtD
Clavulanate—Haemoglobin—Prednisone—hematologic cancer	0.000741	0.000741	CcSEcCtD
Clavulanate—Haemorrhage—Prednisone—hematologic cancer	0.000737	0.000737	CcSEcCtD
Clavulanate—Rash—Hydroxyurea—hematologic cancer	0.000737	0.000737	CcSEcCtD
Clavulanate—Dermatitis—Hydroxyurea—hematologic cancer	0.000737	0.000737	CcSEcCtD
Clavulanate—Urticaria—Ifosfamide—hematologic cancer	0.000735	0.000735	CcSEcCtD
Clavulanate—Pain—Gemcitabine—hematologic cancer	0.000732	0.000732	CcSEcCtD
Clavulanate—Anaphylactic shock—Etoposide—hematologic cancer	0.000731	0.000731	CcSEcCtD
Clavulanate—Diarrhoea—Vinorelbine—hematologic cancer	0.000729	0.000729	CcSEcCtD
Clavulanate—Hypersensitivity—Thalidomide—hematologic cancer	0.000725	0.000725	CcSEcCtD
Clavulanate—Nausea—Melphalan—hematologic cancer	0.000725	0.000725	CcSEcCtD
Clavulanate—Anaphylactic shock—Prednisolone—hematologic cancer	0.000721	0.000721	CcSEcCtD
Clavulanate—Pruritus—Thiotepa—hematologic cancer	0.00072	0.00072	CcSEcCtD
Clavulanate—Thrombocytopenia—Etoposide—hematologic cancer	0.000716	0.000716	CcSEcCtD
Clavulanate—Eosinophilia—Epirubicin—hematologic cancer	0.000713	0.000713	CcSEcCtD
Clavulanate—Nausea—Lenalidomide—hematologic cancer	0.000704	0.000704	CcSEcCtD
Clavulanate—Convulsion—Triamcinolone—hematologic cancer	0.000704	0.000704	CcSEcCtD
Clavulanate—Hypokalaemia—Doxorubicin—hematologic cancer	0.000702	0.000702	CcSEcCtD
Clavulanate—Urticaria—Mitoxantrone—hematologic cancer	0.000698	0.000698	CcSEcCtD
Clavulanate—Hypersensitivity—Carmustine—hematologic cancer	0.000696	0.000696	CcSEcCtD
Clavulanate—Pruritus—Thalidomide—hematologic cancer	0.000696	0.000696	CcSEcCtD
Clavulanate—Diarrhoea—Thiotepa—hematologic cancer	0.000696	0.000696	CcSEcCtD
Clavulanate—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	0.000695	0.000695	CcSEcCtD
Clavulanate—Nausea—Hydroxyurea—hematologic cancer	0.000695	0.000695	CcSEcCtD
Clavulanate—Vomiting—Bortezomib—hematologic cancer	0.000694	0.000694	CcSEcCtD
Clavulanate—Hypersensitivity—Alitretinoin—hematologic cancer	0.00069	0.00069	CcSEcCtD
Clavulanate—Vomiting—Bleomycin—hematologic cancer	0.000689	0.000689	CcSEcCtD
Clavulanate—Rash—Bortezomib—hematologic cancer	0.000688	0.000688	CcSEcCtD
Clavulanate—Dermatitis—Bortezomib—hematologic cancer	0.000687	0.000687	CcSEcCtD
Clavulanate—Rash—Bleomycin—hematologic cancer	0.000683	0.000683	CcSEcCtD
Clavulanate—Pain—Cisplatin—hematologic cancer	0.000682	0.000682	CcSEcCtD
Clavulanate—Dermatitis—Bleomycin—hematologic cancer	0.000682	0.000682	CcSEcCtD
Clavulanate—Hypersensitivity—Ifosfamide—hematologic cancer	0.000682	0.000682	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	0.000681	0.000681	CcSEcCtD
Clavulanate—Vomiting—Vinorelbine—hematologic cancer	0.000678	0.000678	CcSEcCtD
Clavulanate—Diarrhoea—Thalidomide—hematologic cancer	0.000673	0.000673	CcSEcCtD
Clavulanate—Rash—Vinorelbine—hematologic cancer	0.000672	0.000672	CcSEcCtD
Clavulanate—Dermatitis—Vinorelbine—hematologic cancer	0.000671	0.000671	CcSEcCtD
Clavulanate—Hypersensitivity—Vincristine—hematologic cancer	0.000665	0.000665	CcSEcCtD
Clavulanate—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000663	0.000663	CcSEcCtD
Clavulanate—Pruritus—Alitretinoin—hematologic cancer	0.000663	0.000663	CcSEcCtD
Clavulanate—Eosinophilia—Doxorubicin—hematologic cancer	0.00066	0.00066	CcSEcCtD
Clavulanate—Pruritus—Ifosfamide—hematologic cancer	0.000655	0.000655	CcSEcCtD
Clavulanate—Nausea—Bortezomib—hematologic cancer	0.000648	0.000648	CcSEcCtD
Clavulanate—Hypersensitivity—Irinotecan—hematologic cancer	0.000648	0.000648	CcSEcCtD
Clavulanate—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000648	0.000648	CcSEcCtD
Clavulanate—Vomiting—Thiotepa—hematologic cancer	0.000647	0.000647	CcSEcCtD
Clavulanate—Diarrhoea—Carmustine—hematologic cancer	0.000647	0.000647	CcSEcCtD
Clavulanate—Nausea—Bleomycin—hematologic cancer	0.000643	0.000643	CcSEcCtD
Clavulanate—Rash—Thiotepa—hematologic cancer	0.000642	0.000642	CcSEcCtD
Clavulanate—Dermatitis—Thiotepa—hematologic cancer	0.000641	0.000641	CcSEcCtD
Clavulanate—Diarrhoea—Alitretinoin—hematologic cancer	0.000641	0.000641	CcSEcCtD
Clavulanate—Convulsion—Dexamethasone—hematologic cancer	0.000639	0.000639	CcSEcCtD
Clavulanate—Convulsion—Betamethasone—hematologic cancer	0.000639	0.000639	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.000637	0.000637	CcSEcCtD
Clavulanate—Diarrhoea—Ifosfamide—hematologic cancer	0.000633	0.000633	CcSEcCtD
Clavulanate—Nausea—Vinorelbine—hematologic cancer	0.000633	0.000633	CcSEcCtD
Clavulanate—Vomiting—Thalidomide—hematologic cancer	0.000626	0.000626	CcSEcCtD
Clavulanate—Pain—Etoposide—hematologic cancer	0.000625	0.000625	CcSEcCtD
Clavulanate—Rash—Thalidomide—hematologic cancer	0.000621	0.000621	CcSEcCtD
Clavulanate—Dermatitis—Thalidomide—hematologic cancer	0.00062	0.00062	CcSEcCtD
Clavulanate—Haemoglobin—Methotrexate—hematologic cancer	0.000619	0.000619	CcSEcCtD
Clavulanate—Diarrhoea—Vincristine—hematologic cancer	0.000617	0.000617	CcSEcCtD
Clavulanate—Pain—Prednisolone—hematologic cancer	0.000617	0.000617	CcSEcCtD
Clavulanate—Haemorrhage—Methotrexate—hematologic cancer	0.000616	0.000616	CcSEcCtD
Clavulanate—Hepatitis—Methotrexate—hematologic cancer	0.000616	0.000616	CcSEcCtD
Clavulanate—Pruritus—Gemcitabine—hematologic cancer	0.000606	0.000606	CcSEcCtD
Clavulanate—Nausea—Thiotepa—hematologic cancer	0.000604	0.000604	CcSEcCtD
Clavulanate—Anaphylactic shock—Betamethasone—hematologic cancer	0.000602	0.000602	CcSEcCtD
Clavulanate—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000602	0.000602	CcSEcCtD
Clavulanate—Diarrhoea—Mitoxantrone—hematologic cancer	0.000601	0.000601	CcSEcCtD
Clavulanate—Diarrhoea—Irinotecan—hematologic cancer	0.000601	0.000601	CcSEcCtD
Clavulanate—Vomiting—Carmustine—hematologic cancer	0.000601	0.000601	CcSEcCtD
Clavulanate—Rash—Carmustine—hematologic cancer	0.000596	0.000596	CcSEcCtD
Clavulanate—Dermatitis—Carmustine—hematologic cancer	0.000596	0.000596	CcSEcCtD
Clavulanate—Vomiting—Alitretinoin—hematologic cancer	0.000595	0.000595	CcSEcCtD
Clavulanate—Rash—Alitretinoin—hematologic cancer	0.00059	0.00059	CcSEcCtD
Clavulanate—Dermatitis—Alitretinoin—hematologic cancer	0.00059	0.00059	CcSEcCtD
Clavulanate—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000589	0.000589	CcSEcCtD
Clavulanate—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000589	0.000589	CcSEcCtD
Clavulanate—Thrombocytopenia—Betamethasone—hematologic cancer	0.000589	0.000589	CcSEcCtD
Clavulanate—Vomiting—Ifosfamide—hematologic cancer	0.000588	0.000588	CcSEcCtD
Clavulanate—Hypersensitivity—Cisplatin—hematologic cancer	0.000588	0.000588	CcSEcCtD
Clavulanate—Diarrhoea—Gemcitabine—hematologic cancer	0.000586	0.000586	CcSEcCtD
Clavulanate—Nausea—Thalidomide—hematologic cancer	0.000585	0.000585	CcSEcCtD
Clavulanate—Rash—Ifosfamide—hematologic cancer	0.000584	0.000584	CcSEcCtD
Clavulanate—Dermatitis—Ifosfamide—hematologic cancer	0.000583	0.000583	CcSEcCtD
Clavulanate—Erythema multiforme—Methotrexate—hematologic cancer	0.000583	0.000583	CcSEcCtD
Clavulanate—Urticaria—Etoposide—hematologic cancer	0.000581	0.000581	CcSEcCtD
Clavulanate—Haemoglobin—Epirubicin—hematologic cancer	0.00058	0.00058	CcSEcCtD
Clavulanate—Haemorrhage—Epirubicin—hematologic cancer	0.000577	0.000577	CcSEcCtD
Clavulanate—Hepatitis—Epirubicin—hematologic cancer	0.000577	0.000577	CcSEcCtD
Clavulanate—Vomiting—Vincristine—hematologic cancer	0.000574	0.000574	CcSEcCtD
Clavulanate—Urticaria—Prednisolone—hematologic cancer	0.000573	0.000573	CcSEcCtD
Clavulanate—Rash—Vincristine—hematologic cancer	0.000569	0.000569	CcSEcCtD
Clavulanate—Dermatitis—Vincristine—hematologic cancer	0.000568	0.000568	CcSEcCtD
Clavulanate—Pain—Triamcinolone—hematologic cancer	0.000567	0.000567	CcSEcCtD
Clavulanate—Nausea—Carmustine—hematologic cancer	0.000562	0.000562	CcSEcCtD
Clavulanate—Vomiting—Mitoxantrone—hematologic cancer	0.000559	0.000559	CcSEcCtD
Clavulanate—Vomiting—Irinotecan—hematologic cancer	0.000559	0.000559	CcSEcCtD
Clavulanate—Nausea—Alitretinoin—hematologic cancer	0.000556	0.000556	CcSEcCtD
Clavulanate—Convulsion—Prednisone—hematologic cancer	0.000556	0.000556	CcSEcCtD
Clavulanate—Rash—Mitoxantrone—hematologic cancer	0.000554	0.000554	CcSEcCtD
Clavulanate—Rash—Irinotecan—hematologic cancer	0.000554	0.000554	CcSEcCtD
Clavulanate—Dermatitis—Mitoxantrone—hematologic cancer	0.000554	0.000554	CcSEcCtD
Clavulanate—Dermatitis—Irinotecan—hematologic cancer	0.000554	0.000554	CcSEcCtD
Clavulanate—Nausea—Ifosfamide—hematologic cancer	0.00055	0.00055	CcSEcCtD
Clavulanate—Diarrhoea—Cisplatin—hematologic cancer	0.000546	0.000546	CcSEcCtD
Clavulanate—Erythema multiforme—Epirubicin—hematologic cancer	0.000545	0.000545	CcSEcCtD
Clavulanate—Vomiting—Gemcitabine—hematologic cancer	0.000544	0.000544	CcSEcCtD
Clavulanate—Rash—Gemcitabine—hematologic cancer	0.00054	0.00054	CcSEcCtD
Clavulanate—Dermatitis—Gemcitabine—hematologic cancer	0.000539	0.000539	CcSEcCtD
Clavulanate—Hypersensitivity—Etoposide—hematologic cancer	0.000539	0.000539	CcSEcCtD
Clavulanate—Haemoglobin—Doxorubicin—hematologic cancer	0.000536	0.000536	CcSEcCtD
Clavulanate—Nausea—Vincristine—hematologic cancer	0.000536	0.000536	CcSEcCtD
Clavulanate—Haemorrhage—Doxorubicin—hematologic cancer	0.000534	0.000534	CcSEcCtD
Clavulanate—Hepatitis—Doxorubicin—hematologic cancer	0.000534	0.000534	CcSEcCtD
Clavulanate—Hypersensitivity—Prednisolone—hematologic cancer	0.000531	0.000531	CcSEcCtD
Clavulanate—Urticaria—Triamcinolone—hematologic cancer	0.000527	0.000527	CcSEcCtD
Clavulanate—Anaphylactic shock—Prednisone—hematologic cancer	0.000524	0.000524	CcSEcCtD
Clavulanate—Nausea—Mitoxantrone—hematologic cancer	0.000522	0.000522	CcSEcCtD
Clavulanate—Nausea—Irinotecan—hematologic cancer	0.000522	0.000522	CcSEcCtD
Clavulanate—Pruritus—Etoposide—hematologic cancer	0.000517	0.000517	CcSEcCtD
Clavulanate—Pain—Betamethasone—hematologic cancer	0.000514	0.000514	CcSEcCtD
Clavulanate—Pain—Dexamethasone—hematologic cancer	0.000514	0.000514	CcSEcCtD
Clavulanate—Nausea—Gemcitabine—hematologic cancer	0.000509	0.000509	CcSEcCtD
Clavulanate—Vomiting—Cisplatin—hematologic cancer	0.000507	0.000507	CcSEcCtD
Clavulanate—Erythema multiforme—Doxorubicin—hematologic cancer	0.000505	0.000505	CcSEcCtD
Clavulanate—Rash—Cisplatin—hematologic cancer	0.000503	0.000503	CcSEcCtD
Clavulanate—Dermatitis—Cisplatin—hematologic cancer	0.000503	0.000503	CcSEcCtD
Clavulanate—Diarrhoea—Etoposide—hematologic cancer	0.0005	0.0005	CcSEcCtD
Clavulanate—Hypersensitivity—Triamcinolone—hematologic cancer	0.000489	0.000489	CcSEcCtD
Clavulanate—Leukopenia—Methotrexate—hematologic cancer	0.00048	0.00048	CcSEcCtD
Clavulanate—Urticaria—Dexamethasone—hematologic cancer	0.000478	0.000478	CcSEcCtD
Clavulanate—Urticaria—Betamethasone—hematologic cancer	0.000478	0.000478	CcSEcCtD
Clavulanate—Nausea—Cisplatin—hematologic cancer	0.000474	0.000474	CcSEcCtD
Clavulanate—Pruritus—Triamcinolone—hematologic cancer	0.000469	0.000469	CcSEcCtD
Clavulanate—Convulsion—Methotrexate—hematologic cancer	0.000465	0.000465	CcSEcCtD
Clavulanate—Vomiting—Etoposide—hematologic cancer	0.000465	0.000465	CcSEcCtD
Clavulanate—Rash—Etoposide—hematologic cancer	0.000461	0.000461	CcSEcCtD
Clavulanate—Dermatitis—Etoposide—hematologic cancer	0.00046	0.00046	CcSEcCtD
Clavulanate—Rash—Prednisolone—hematologic cancer	0.000455	0.000455	CcSEcCtD
Clavulanate—Dermatitis—Prednisolone—hematologic cancer	0.000454	0.000454	CcSEcCtD
Clavulanate—Leukopenia—Epirubicin—hematologic cancer	0.000449	0.000449	CcSEcCtD
Clavulanate—Anaphylactic shock—Methotrexate—hematologic cancer	0.000438	0.000438	CcSEcCtD
Clavulanate—Convulsion—Epirubicin—hematologic cancer	0.000435	0.000435	CcSEcCtD
Clavulanate—Nausea—Etoposide—hematologic cancer	0.000434	0.000434	CcSEcCtD
Clavulanate—Thrombocytopenia—Methotrexate—hematologic cancer	0.000429	0.000429	CcSEcCtD
Clavulanate—Nausea—Prednisolone—hematologic cancer	0.000428	0.000428	CcSEcCtD
Clavulanate—Pruritus—Dexamethasone—hematologic cancer	0.000426	0.000426	CcSEcCtD
Clavulanate—Pruritus—Betamethasone—hematologic cancer	0.000426	0.000426	CcSEcCtD
Clavulanate—Vomiting—Triamcinolone—hematologic cancer	0.000422	0.000422	CcSEcCtD
Clavulanate—Rash—Triamcinolone—hematologic cancer	0.000418	0.000418	CcSEcCtD
Clavulanate—Dermatitis—Triamcinolone—hematologic cancer	0.000418	0.000418	CcSEcCtD
Clavulanate—Urticaria—Prednisone—hematologic cancer	0.000416	0.000416	CcSEcCtD
Clavulanate—Leukopenia—Doxorubicin—hematologic cancer	0.000416	0.000416	CcSEcCtD
Clavulanate—Diarrhoea—Betamethasone—hematologic cancer	0.000412	0.000412	CcSEcCtD
Clavulanate—Diarrhoea—Dexamethasone—hematologic cancer	0.000412	0.000412	CcSEcCtD
Clavulanate—Anaphylactic shock—Epirubicin—hematologic cancer	0.00041	0.00041	CcSEcCtD
Clavulanate—Convulsion—Doxorubicin—hematologic cancer	0.000403	0.000403	CcSEcCtD
Clavulanate—Thrombocytopenia—Epirubicin—hematologic cancer	0.000401	0.000401	CcSEcCtD
Clavulanate—Nausea—Triamcinolone—hematologic cancer	0.000394	0.000394	CcSEcCtD
Clavulanate—Hypersensitivity—Prednisone—hematologic cancer	0.000386	0.000386	CcSEcCtD
Clavulanate—Vomiting—Betamethasone—hematologic cancer	0.000383	0.000383	CcSEcCtD
Clavulanate—Vomiting—Dexamethasone—hematologic cancer	0.000383	0.000383	CcSEcCtD
Clavulanate—Rash—Dexamethasone—hematologic cancer	0.000379	0.000379	CcSEcCtD
Clavulanate—Rash—Betamethasone—hematologic cancer	0.000379	0.000379	CcSEcCtD
Clavulanate—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000379	0.000379	CcSEcCtD
Clavulanate—Dermatitis—Dexamethasone—hematologic cancer	0.000379	0.000379	CcSEcCtD
Clavulanate—Dermatitis—Betamethasone—hematologic cancer	0.000379	0.000379	CcSEcCtD
Clavulanate—Pain—Methotrexate—hematologic cancer	0.000374	0.000374	CcSEcCtD
Clavulanate—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000371	0.000371	CcSEcCtD
Clavulanate—Pruritus—Prednisone—hematologic cancer	0.000371	0.000371	CcSEcCtD
Clavulanate—Diarrhoea—Prednisone—hematologic cancer	0.000358	0.000358	CcSEcCtD
Clavulanate—Nausea—Betamethasone—hematologic cancer	0.000357	0.000357	CcSEcCtD
Clavulanate—Nausea—Dexamethasone—hematologic cancer	0.000357	0.000357	CcSEcCtD
Clavulanate—Pain—Epirubicin—hematologic cancer	0.00035	0.00035	CcSEcCtD
Clavulanate—Urticaria—Methotrexate—hematologic cancer	0.000348	0.000348	CcSEcCtD
Clavulanate—Vomiting—Prednisone—hematologic cancer	0.000333	0.000333	CcSEcCtD
Clavulanate—Rash—Prednisone—hematologic cancer	0.00033	0.00033	CcSEcCtD
Clavulanate—Dermatitis—Prednisone—hematologic cancer	0.00033	0.00033	CcSEcCtD
Clavulanate—Urticaria—Epirubicin—hematologic cancer	0.000326	0.000326	CcSEcCtD
Clavulanate—Pain—Doxorubicin—hematologic cancer	0.000324	0.000324	CcSEcCtD
Clavulanate—Hypersensitivity—Methotrexate—hematologic cancer	0.000323	0.000323	CcSEcCtD
Clavulanate—Nausea—Prednisone—hematologic cancer	0.000311	0.000311	CcSEcCtD
Clavulanate—Pruritus—Methotrexate—hematologic cancer	0.00031	0.00031	CcSEcCtD
Clavulanate—Hypersensitivity—Epirubicin—hematologic cancer	0.000302	0.000302	CcSEcCtD
Clavulanate—Urticaria—Doxorubicin—hematologic cancer	0.000301	0.000301	CcSEcCtD
Clavulanate—Diarrhoea—Methotrexate—hematologic cancer	0.0003	0.0003	CcSEcCtD
Clavulanate—Pruritus—Epirubicin—hematologic cancer	0.00029	0.00029	CcSEcCtD
Clavulanate—Diarrhoea—Epirubicin—hematologic cancer	0.00028	0.00028	CcSEcCtD
Clavulanate—Hypersensitivity—Doxorubicin—hematologic cancer	0.000279	0.000279	CcSEcCtD
Clavulanate—Vomiting—Methotrexate—hematologic cancer	0.000278	0.000278	CcSEcCtD
Clavulanate—Rash—Methotrexate—hematologic cancer	0.000276	0.000276	CcSEcCtD
Clavulanate—Dermatitis—Methotrexate—hematologic cancer	0.000276	0.000276	CcSEcCtD
Clavulanate—Pruritus—Doxorubicin—hematologic cancer	0.000268	0.000268	CcSEcCtD
Clavulanate—Vomiting—Epirubicin—hematologic cancer	0.000261	0.000261	CcSEcCtD
Clavulanate—Nausea—Methotrexate—hematologic cancer	0.00026	0.00026	CcSEcCtD
Clavulanate—Diarrhoea—Doxorubicin—hematologic cancer	0.000259	0.000259	CcSEcCtD
Clavulanate—Rash—Epirubicin—hematologic cancer	0.000258	0.000258	CcSEcCtD
Clavulanate—Dermatitis—Epirubicin—hematologic cancer	0.000258	0.000258	CcSEcCtD
Clavulanate—Nausea—Epirubicin—hematologic cancer	0.000243	0.000243	CcSEcCtD
Clavulanate—Vomiting—Doxorubicin—hematologic cancer	0.000241	0.000241	CcSEcCtD
Clavulanate—Rash—Doxorubicin—hematologic cancer	0.000239	0.000239	CcSEcCtD
Clavulanate—Dermatitis—Doxorubicin—hematologic cancer	0.000239	0.000239	CcSEcCtD
Clavulanate—Nausea—Doxorubicin—hematologic cancer	0.000225	0.000225	CcSEcCtD
